Institutional long-term outcomes at the first Canadian center performing intraoperatively planned low-dose-rate brachytherapy alone in low- and intermediate-risk prostate cancer.

Peacock, Michael; Martell, Kevin; Taggar, Amandeep; Meyer, Tyler; Smith, Wendy; Sia, Michael; Angyalfi, Steve; Husain, Siraj

Peacock, Michael; Martell, Kevin; Taggar, Amandeep; Meyer, Tyler; Smith, Wendy; Sia, Michael; Angyalfi, Steve; Husain, Siraj.

Afiliación

Peacock M; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Martell K; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Taggar A; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Meyer T; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Smith W; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Sia M; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Angyalfi S; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Husain S; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada. Electronic address: siraj.husain@albertahealthservices.ca.

Brachytherapy ; 16(4): 822-830, 2017.

Article en En | MEDLINE | ID: mdl-28460998

Palabras clave

Biochemical recurrence; Brachytherapy; Erectile function; Intraoperative; Prostate neoplasm

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Brachytherapy Asunto de la revista: RADIOTERAPIA Año: 2017 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google